1900 Wealth Management LLC Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

1900 Wealth Management LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 388 shares of the healthcare conglomerate’s stock, valued at approximately $203,000.

Other institutional investors have also made changes to their positions in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $32,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.8%

Shares of UnitedHealth Group stock opened at $307.84 on Tuesday. The firm’s 50-day moving average price is $381.74 and its two-hundred day moving average price is $470.20. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $279.25 billion, a price-to-earnings ratio of 19.86, a PEG ratio of 1.37 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.87%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.

Insider Buying and Selling

In other news, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last ninety days. Company insiders own 0.28% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on UNH shares. Truist Financial reiterated a “buy” rating and issued a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. TD Securities reissued a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $426.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.